News & Analysis on Clinical Trial Services & Contract Research And Development
Bayer Diagnostics and Innogenetics have launched an assay that allows genotyping for the Hepatitis C Virus (HCV), permitting broader identification of HCV genotypes with improved accuracy, not possible by current HCV genotyping products.
Scientists have managed to gain unique insights into the future design of drugs for a selection of medical conditions using innovative NMR equipment to study a range of biological processes.
Surface Logix has presented encouraging Phase 1 trial data for a drug candidate that is being developed for the treatment of abnormal levels of lipids in the bloodstream - a condition that affects approximately 10 per cent of the global population.
A new X-ray microscopy technique will enable scientists to view materials less than a nanometre in size. The development will help scientists visualise reactions at surfaces, such as corrosion and catalytic reactions, in real-time.